Brief: Eris Receives ANVISA Approval For Sterile Injectable Facility
Aug 26 (Reuters) - Eris Lifesciences Ltd ERIS.NS: ERIS LIFESCIENCES RECEIVES ANVISA APPROVAL FOR STERILE INJECTABLE FACILITY Source text: ID:nnAZN4F39GP Further company coverage: ERIS.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Eris Lifesciences
See all newsIndia's Eris Lifesciences gains on strong quarterly results
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.84 Billion Rupees
Brief: Eris Lifesciences Says Krishnakumar Vaidyanathan Resigns As Executive Director & COO
Brief: Eris Lifesciences Ltd Says June-Quarter Consol Net Profit 1.42 Billion Rupees
Brief: Eris Lifesciences March-Quarter Consol Net Profit 2.82 Billion Rupees